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Abstract
Introduction: Lung transplant recipients face challenging postoperative complications and are at risk for poor sleep quality.
Sleep quality, as a complex clinical phenomenon, has multiple subjective and objective connotations. Measures and deﬁnitions
of sleep quality are not standardized. Objective: A scoping review methodology was used to systematically map the relevant
literature, provide an overview of available sleep quality measures, and to identify knowledge gaps. Methods: A systematic search
of published and gray literature enabled knowledge synthesis of the last 10 years of evidence documenting sleep quality in lung
transplant recipients. The search revealed 246 articles with only 12 sources meeting the eligibility criteria. Results: Sources varied in terms of deﬁnitions and measures of sleep quality. Subjective, objective, or a combination of both measures were used
across the relevant literature with ﬁndings conﬁrming that poor sleep quality was common in lung transplant recipients.
Signiﬁcant associations with poor sleep quality included younger age, female gender, exposure to tacrolimus, anxiety, and depression. Discussion: Systematic literature assessing sleep quality in lung transplant recipients is sparse and lacks conceptual and
operational deﬁnitions. Future research can focus on designing prospective observational studies. Subjective and objective measures for sleep quality need to be validated in lung transplant recipients. Further rigorous research is needed to standardize measures of sleep quality and to further examine potential risk factors that affect sleep after lung transplantation.
Keywords
lung transplantation, lung transplant recipients, sleep, sleep quality, scoping review

Introduction
Lung transplantation is a treatment strategy for individuals with endstage lung disease that is no longer amenable to conventional treatments. After the lung transplant surgery, patients continue to face a
plethora of complications. Risks of allograft rejection and infections
become a lifelong concern while the complicated posttransplant
medical regimen may lead to the development of diabetes, hypertension, osteoporosis, and malignancies.1,2 Hence, the median survival
for adults undergoing lung transplantation is only 6.7 years,1 which
is an improvement from previous decades due to advances in immunosuppressive, medical, and surgical techniques. In conjunction
with these improvements, there is an increased awareness of the
role of sleep in the development and management of chronic diseases and health. Sleep is an essential physiological function to
maintain one’s physical, cognitive, and psychological health.3,4
Circulatory, respiratory, musculoskeletal, and central nervous
systems are repaired during sleep.5 Consistent lack of sleep or sleeping less than the recommended amount is associated with adverse
health outcomes such as obesity, diabetes, cardiovascular disease,
impaired immunity, neurocognitive dysfunction, depression,
anxiety, poor quality of life and increased risk of death.4,6–8

and vitality.9 Often, patients who are dissatisﬁed with their sleep
quality refer to difﬁculties with nighttime sleep when provided
with an opportunity to sleep (eg, insomnia), daytime consequences
due to poor sleep (eg, daytime sleepiness), nocturnal movements
(eg, jerking of legs and sleep walking), or a combination of these
concerns.7,8 Yet, despite its common use, sleep quality as a
concept has not been rigorously deﬁned.3,9–12 Sleep quality is
likely to have different connotations from one person to the next.13

Sleep Quality Assessment
Standardized measurements of sleep quality have also not been universally agreed upon due to the vague deﬁnitions of the underlying
concept.13 Buysse et al11 postulated that sleep quality included quantitative measures of sleep, such as sleep duration and sleep latency, in
addition to subjective aspects such as restfulness of sleep. Hence,
sleep quality assessments have been attempted using subjective and
objective sleep parameters and self-report questionnaires.13
Sleep quality can be measured by sleep parameters related to
the sleep-wake cycle.14 These measures include total sleep
1
2

Sleep Quality
The term sleep quality is often used by patients, clinicians and
research professionals alike who have all associated it with health
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time, sleep onset latency, and sleep efﬁciency (Table 1).9,12,15,16
These indices can be measured subjectively, via patients’ selfreports, or objectively from the physiological parameters generated from polysomnography), actigraphy, and wearable sleep
trackers.11,12,17–22
While polysomnography is the gold standard for physiologically measuring sleep and diagnosing sleep disorders,17 it is
expensive and takes place in a medical setting as opposed to
actigraphy, which is an activity-based assessment of sleep
quality worn as a wristwatch or as an attachment to the belt.23
Actigraphy devices measure motions with an idea that people
move when awake with progressive reduction in motion
when asleep, discriminating sleep and wake cycles.18 The
sleep efﬁciency and total sleep time measured with actigraphy
devices reﬂect the polysomnographic sleep parameters and
have been validated in healthy and clinical populations.19
Spielmanns et al18 found that these devices have advantages
of convenience of use, cost effectiveness, and continuous
recording. Compared to polysomnography, sleep data are collected an individual’s home, as opposed to a sleep laboratory.
Similar to actigraphy devices, wearable sleep-trackers, show
high sensitivity (above 90%) in detecting sleep but lower speciﬁcity in detecting wake cycle due to an overestimation of
total sleep time and underestimation of wake after sleep
onset.19 Further investigations are recommended to establish
their empirical validity in monitoring sleep.19
Several instruments are available to measure sleep quality
using self-report questionnaires that evaluate various domains
of the sleep experience.13 The most commonly used self-reports
are the Pittsburgh Sleep Quality Index (PSQI),11 Insomnia
Severity Scale (ISI),20,21 and Epworth Sleepiness Scale
(ESS).22 These tools allow for an individual’s subjective
appraisal of sleep and are summarized in Table 2.

Lung Transplantation
Patients after lung transplantation, similar to other solid organ
recipients, are at an increased risk for poor sleep due to medications and comorbidities.24 However, the understanding of sleep
quality and its measures in lung transplant recipients is unclear.
A preliminary search for existing scoping or systematic reviews
on the topic was conducted using Cochrane Database of
Systematic Reviews, JBI Evidence, and PubMed, and none
were identiﬁed. Given the absence of evidence synthesis on
this topic, the authors pursued a scoping review methodology
to raise awareness of this gap among the clinical and academic
transplant community.

Objective
The objective of this scoping review was to systematically
map the literature available in the area of sleep quality in
lung transplant recipients, provide an overview of available
measures, and to identify knowledge gaps. It aimed to
address the following research questions: (a) What is the
range of research that examined sleep quality in lung
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Table 1. Sleep Quality Indices and Deﬁnitions.
Sleep Quality
Index
Total sleep time
(TST)

Sleep latency
(SL) or sleep
onset latency
Sleep efﬁciency
(SE)

Rapid eye
movement
(REM) sleep
Wake time after
sleep onset

Deﬁnition

Accepted Values

“Total amount of sleep A low TST (<6 hours)
may be indicative of
time scored during
insufﬁcient sleep
the total recording
duration while
ime”,15pg.2
prolonged TST may
suggest effects of
medications, medical
conditions, or prior
sleep deprivation15
Duration of time in
Falling asleep within
minutes that it takes
30 minutes or less
for an individual to
after going to bed16
fall asleep15,16
Calculates the
This measurement
percentage of total
should be 85% or
time in bed that is
more for optimal
spent in sleep15
health beneﬁts16
REM sleep of 21%-30%
Percentage of time
indicates good
spent in REM sleep
objective sleep quality9
compared to total
sleep16
Calculates amount of
time awake after
initiation of sleep16

transplant recipients and what were the characteristics of
these studies? (b) What instruments (subjective and objective)
were used to measure sleep quality in lung transplant recipients? (c) What were the primary results of the studies of
sleep quality in lung transplant recipients?

Methods
Protocol and Registration
The protocol was developed a priori following guidelines for
conducting scoping reviews recommended by methodology
outlined by Arksey and O’Malley25 and subsequently adapted
by Joanna Briggs Institute.26 The Preferred Reporting Items
for Systematic reviews and Meta-Analyzes extension for
Scoping Reviews (PRISMA-ScR)27 was used to provide reporting guidance.

Eligibility Criteria
The primary concept of the review was sleep quality and, therefore, to be included in this review, articles had to discuss the
concept of sleep quality, its associated constructs, or measures.
This scoping review included literature of lung transplant recipients, male or female, 18 years and older, of any ethnicity, transplanted at any global transplant center. Studies of sleep quality
in solid organ transplant patients that included sub-samples of
lung transplant recipients were also considered. Research
designs inclusive of quantitative, qualitative, and mixed
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Table 2. Sleep Quality Measures and Instruments with Associated Descriptions.
Measure
Objective Measures
Polysomnography
Actigraphy

Wearable sleep-trackers
Self-report Instruments
Pittsburgh Sleep Quality Index
(PSQI)11
Insomnia Severity Scale (ISI)20,21

Epworth Sleepiness Scale (ESS)22

Description
Quantiﬁes sleep latency, total sleep time, wake time after sleep onset, as well as sleep phases such as REM
sleep and non-REM sleep12,17
Relies on an accelerometer to measure motion with the premise that people move when awake with
progressive reduction in motion when asleep, especially in the deepest stages of sleep, discriminating sleep
and wake cycles18
Convenient to use, cost effective, and provide continuous recording18
Measure signals such as heart rate, skin conductance, and motion from which the information about sleep is
derived19
19-item self-report questionnaire assessing global sleep quality score and 7 component scores: Sleep Quality,
Sleep Latency, sleep duration, habitual sleep efﬁciency (the ratio of sleep duration by time spent in bed),
sleep disturbance (eg using the washroom), use of sleeping medications, and daytime dysfunction.11
A global PSQI score of 5 or higher provides a sensitive and speciﬁc measure of poor sleep quality11
7-item instrument that measures patient’s perceptions of insomnia. It evaluates insomnia over the past 2-4
weeks with particular attention to sleep onset, sleep maintenance, early morning awakenings, satisfaction
with current sleep pattern, interference with daily functioning, and noticeability of sleep problems by
others.
An ISI score of greater than 7 is classiﬁed into various levels of insomnia from mild to severe and a score
greater than 10 is a clinical threshold for insomnia.20,21
Assesses daytime sleepiness.22
Evaluates the probability of falling asleep in common situations of daily life.
The ESS score ranges from 0-24 with higher scores reﬂecting excessive daytime sleepiness22

REM = rapid eye movement.

methods studies were eligible. Gray literature, including conference abstracts, poster presentations, and dissertations was also
eligible. Studies of pediatric populations under the age of 18
years and articles in a language other than English were
excluded. Literature published over 10 years ago were excluded
to target results relevant to a practicing audience and minimize
introducing biases that may be associated with outdated transplant practices.

Information Sources
The database selection was based on a consultation with two
librarians: clinical and academic. Source, for the purposes of
this scoping review, refers to the included literature. To minimize missed sources and bias, several electronic databases
were searched and included Medline PubMed, Embase,
Cochrane Central Register of Controlled Trials, Cochrane
Database of Systematic Reviews, PsycINFO, Cumulative
Index to Nursing and Allied Health Literature (CINAHL),
Scopus, and Web of Science. The trials register, clinicaltrials.gov, was searched for additional trials. The search for gray literature included the ProQuest Dissertations and Thesis,
New York Academy of Medicine, and Google Scholar.
Additional search strategies included hand searches of
included key studies found through the database searches.
The searches took place on multiple dates between January
and February 2021, with the last search taking place on
February 20, 2021.

Search Strategy
The search strategy aimed to identify both published and unpublished sources. A 3-step search strategy was used. The ﬁrst step
was an initial limited search of two online databases (PubMed
and Embase) relevant to the topic. This initial search was constructed around the terms lung transplant and sleep quality, followed by an analysis of the text words in the title and abstracts
of retrieved articles and of the index terms used to describe the
article. The authors conducted a second search using all identiﬁed
keywords and index terms. Examples of keyword strings, medical
subject headings (MeSH) terms and truncated words in different
groupings were combined using the Boolean operators and/or and
included: sleep initiation and maintenance or sleep or insomnia or
sleep quality or PSQI and lung transplant*. The literature search
was adapted to each database. Limits of English language and
date ﬁlter were applied at the end of each search. The reference
list of all the identiﬁed articles was searched for additional
sources. The ﬁnal search strategy in Medline PubMed and
Embase are presented in the Supplementary Appendix.

Selecting the Evidence
Zotero reference management software was used to import,
manage, and de-duplicate references. Once de-duplicated,
results were imported into a systematic review manager,
Covidence (Veritas Health Innovation). The authors examined titles and abstracts of the retrieved articles in Level 1
of screening and when considered eligible, sources were
reviewed in full text in Level 2. Inclusion and exclusion of
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Table 3. Literature Regarding Sleep Quality in Lung Transplant Recipients.
Author, Year,
Location, and
Literature Source
Burkhalter et al,
201728
Switzerland
Quantitative
Study

Purpose

Design and Sample

Sleep Quality Measure

Key Findings

1. To detect and compare
changes in sleep quality in solid
organ transplant recipients
over time (pre-, and four
timepoints post-transplant)
2. To compare global quality of
life and survival (until 3 years
post-transplant) in subjects
with persistently poor sleep
quality to those with
consistently good and variable
sleep quality

•

•

•

•
•
•
•
•

Prospective multi-center
design
Convenience sample
N = 1173 organ
transplant patients
Subsample of 123 lung
transplant recipients
Mean age: 49.9 years
Gender: 59% male and
41% female

Subjective: single item
derived from the
‘Kidney Disease
Quality of Life–Short
Form’ instrument,
which was initially
developed for
patients with
end-stage renal
disease

•

•

•

Fatigati et al,
201629
USA
Quantitative
Study

1. To identify the pattern,
•
predictors, and impact of poor
sleep quality on
self-management behaviors
and HRQOL outcomes during
the ﬁrst year after a lung
transplant
•
•
•
•

Secondary analysis of data •
from patients who
•
participated in a
randomized controlled
trial to evaluate a mobile
health intervention
Convenience sample
N = 75
Mean age: 56.1 years
Gender: 66% male and
34% female

Subjective: PSQI
PSQI Global Score >
8 used to identify
poor sleep

•
•

•

•

Gilmour et al,
201530
Australia
Poster Abstract

1. To assess the prevalence of
depression, anxiety, and
quality of life in a cohort of
BOS patients and to
investigate self-reported sleep
disruptions

•
•
•

Design not stated
Convenience sample
47 lung transplant
recipients

•
•

ISI
ESS

•

•
n = 29 without BOS
n = 18 with BOS

30% of lung transplant
recipients experienced
poor sleep quality 36
months post-transplant
Poor sleep quality had
the lowest occurrence
at 12 months after lung
transplant (24%). No
signiﬁcant change over
time was found in lung
transplant recipients.
Patients with
persistently poor sleep
quality score higher on
the depressive
symptomatology and
have lower mean global
quality of life
No increased mortality
risk was found

32.0 to 37.5% were
categorized as poor
sleepers
Poor sleepers improved
their sleep quality at 12
months and good
sleepers showed
stability in sleep quality
over time
The only signiﬁcant
predictor of poor sleep
quality was female
gender (P = .026; odds
ratio = 3.421).
A signiﬁcant inverse
relationship was found
between poor sleep
quality and the mental
component of HRQOL
(r = 0.348, P < .01)

Symptoms of insomnia
were found in 51.7% of
patients with BOS and
in 44.4% of those
without BOS
Analysis of measures of
anxiety and sleep
disturbance did not
reveal any signiﬁcant
differences between the
groups
(continued)
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Table 3. (continued)
Author, Year,
Location, and
Literature Source

Purpose

Design and Sample

Sleep Quality Measure

Key Findings

Hernandez Voth
et al, 201531
Spain
Quantitative
Study

1. To analyze the evolution of
SDB during a follow-up period
of 1 year after the lung
transplant.

•

Prospective
observational descriptive
design
Convenience sample
N = 20

•

•

Reilly-Spong et al,
201324
USA
Quantitative
Study

1. To investigate the prevalence,
characteristics, and correlates
of sleep difﬁculties in solid
organ transplant recipients

Cross-sectional design
Convenience sample
143 solid organ transplant
recipients
Subsample of 12 lung
transplant recipients
Mean age: 54.1 years
Gender: 42% male and
58% female

•

•
•

•
•
•
•
•
•

•

Objective: PSG, TST,
SE
Subjective: ESS

•

Subjective: PSQI

Global score
>5 and >8
Objective: Actigraphy

•
•
•
•
•
•
•
•
•
•
•

Rohde et al,
201732
USA
Quantitative
Study

1. To evaluate the prevalence of
insomnia within lung
transplant clinic
2. To determine whether a
relationship exists between
insomnia and exposure to
immunosuppressant
medications following
transplantation

•
•
•
•
•

Cross-sectional design
Convenience sample
N = 125
Mean age with insomnia
57 years; without
insomnia 55 years
Gender with insomnia:
Male 30%; without
insomnia: Male 62%

•
•

•

Subjective: ISI
(ISI score >10)
Wisconsin Sleep
Cohort Study to
assess the frequency
of sleep complaints
related to insomnia
ESS

•
•
•
•

•

Sawhney et al,
202033
USA

1. To identify the reasons for
poor sleep quality in lung
transplant recipients

•
•
•

Observational;
cross-sectional design
Convenience sample
N = 167

•
•
•

Subjective
PSQI Global score >5
ESS >9

•
•
•

TST 6 months after
transplant 360.2 ±
61.8 minutes; 12
months post-transplant
333.2 ± 74.9 minutes.
SE 6 months after
transplant 82.152 ±
13.3 minutes; 12
months post-transplant
81.8 ± 17.9 minutes

27% lung transplant
recipients had PSQI > 8
and 54.5% > 5
SL > 15 minutes =
66.7%
TST < 7 hours = 30%
SE < 85% = 54.6%
Use of sleep aids = 25%
Sleep disorder diagnosis
= 42%
Actigraphy
TST 6.9 hrs.
TST< 6 hours = 33%
SL = 33.3 minutes
wake after sleep onset
= 48.5 minutes
SE% = 80.9%

The prevalence of
insomnia was 40%
Higher prevalence in
women
ISI cutoff greater than
10.
Those with ISI score
>10 had greater ESS
scores and Sheehan
disability scores.
No difference in time
since transplant was
found, mean tacrolimus
exposure was
signiﬁcantly higher in
patients with insomnia
versus those without
insomnia.

30% had high ESS scores
74% reported poor
sleep
Participants with PSQI
(continued)
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Table 3. (continued)
Author, Year,
Location, and
Literature Source

Purpose

Design and Sample
•
•

Quantitative
Study

Sleep Quality Measure

Key Findings

Mean age: 60.6 years
Gender: 48% male and
52% female
•

•

•

Sommerwerck
et al, 201635
Germany
Quantitative
Study

Smith &
Blumenthal,
201634
USA Letter to
the Editor

1. To determine the prevalence
and clinical predictors of
obstructive sleep apnea in a
cohort of lung transplant
recipients

Not stated

•
•
•
•
•
•
•

Cross-sectional design
Convenience sample
N = 77
Mean Age:
SDB: 56.1 years
Non-SDB 52.4 years
Gender: 58% male and
42% female

Objective: PSG, TST, SE
Subjective: ESS

•
•

Post-hoc analysis
Sample not described

•

•

•
•

Single item of sleep
•
disturbance on BDI-II
•

•

Testelmans et al,
202136
Belgium
Quantitative
Study

1. To evaluate SDB prevalence
and its associated factors at 1
year after lung transplant in a
large cohort

•
•
•
•

Design not stated
Convenience sample
N = 219
Mean age for those with
SDB was 57.9 years and
44.4 years for those with
Non SDB

•
•

Objective: PSG, SE
Subjective: ESS

•
•

> 5 were younger with
no difference in gender
distribution and mean
body mass index.
SL was prolonged
(33.2 minutes) with
mean sleep time of
6.7 hours and low
subjective SE of 78%.
Almost 1/3 of patients
reported sleep initiation
insomnia and more than
2/3 reported
maintenance insomnia.
A higher score on ESS
was noted for
individuals with poor
sleep quality

No statistically
signiﬁcant differences in
TST or SE in SDB or
non-SDB groups
TST in SDB was 323 ±
79 minutes; in non SDB
326 ± 73 minutes
SE was 72.4 ± 13 in SDB
group 71.2 ± 16.8 in
non-SDB group

8% of lung transplant
recipients reported that
their sleep was very
disturbed
5% of lung transplant
recipients reported
more severe sleep
problems
A post hoc exploratory
analysis of the HPI
revealed that
self-reported sleep
disturbance was
associated with greater
depressive

SE in lung transplant
recipients was 70.7% ±
16%
ESS 5.8 ± 4.1

(continued)
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Table 3. (continued)
Author, Year,
Location, and
Literature Source

Tokuno et al,
202037
Japan Abstract

Yo et al, 201938
Australia
Quantitative
Study

Purpose

Design and Sample

Sleep Quality Measure

Key Findings

•

•

Gender: 73% male with
SDB, 36% male without
SDB

1. To assess changes in sleep
quality and other patient
reported measures including
health-related quality of life
after lung transplantation

•

Prospective multi-center
design
Convenience sample
N = 56

•

Global score >5

•

1. To evaluate the prevalence and
potential associations of
insomnia in a lung transplant
cohort

•
•
•
•
•

Cross-sectional design
Convenience sample
N = 81
Mean age: 57 years
Gender: 57% male and
43% female

•

•

•
•

Subjective: PSQI

Subjective:
ISI score >15

•
•

62.5% lung transplant
recipients had poor
sleep quality
In PSQI subscales, sleep
medication worsened
signiﬁcantly (p = .04)
after lung
transplantation

The prevalence of
insomnia was 32%
Insomnia was more
common among
women (51% vs 17%)
There was a signiﬁcant
association between the
HADS scores and
insomnia

BDI-II = Beck Depression Inventory II; BOS = bronchiolitis obliterans syndrome; ESS = Epworth Sleepiness Scale; HADS = Hospital Anxiety and Depression Scale;
HPI = Health Practices Index; HRQOL = health-related quality of life, ISI = Insomnia Severity Index; PSG = polysomnography; PSQI = Pittsburg Sleep Quality
Instrument; SDB = sleep disordered breathing; SE = sleep efﬁciency; SL = sleep latency; TST = total sleep time.

citation abstracts and full-text articles was tracked using
Covidence. After full-text articles were screened for eligibility, the reference lists of all included papers were handsearched for additional sources.

Data Extracting and Charting
Data were extracted from the ﬁnal list of the eligible sources and
charted in Excel (Microsoft Corporation, Redmond, WA) using
a standard data charting form adapted from the Joanna Briggs
Institute. The following information was recorded: author,
year of publication and location; aim of the study; sample characteristics; methodology; sleep quality measures; key ﬁndings
as they related to the scoping review questions; and literature
source. Table 3 summarizes descriptive characteristics and
key ﬁndings of the included sources.24,28–38

Results
Literature Search
After duplicates were removed from the initial 246 sources, the
literature search yielded 184 citations. One hundred thirty-three
sources were found irrelevant after Level 1 screening of titles

and abstracts due to their focus on the populations with pulmonary diseases; pre-transplant or caregivers of lung transplant
recipients; studies of pediatric populations; or focus on pathophysiology or medications. Fifty-one sources were moved for
a full-text review. Level 2 screening excluded 39 sources due
to reasons such as wrong patient population, lack of relevance,
and older than 10 years. Sources from the same group of authors
using identical cohorts of participants were excluded if identical
sleep quality measures were used and reported. After all the
combined searches and completion of Level 2 screening, 12
sources met the inclusion criteria. The number of studies identiﬁed and selected at each stage of the scoping review, along
with the number of articles excluded at each stage with
reasons for exclusion, are presented in a PRISMA ﬂow
diagram in Figure 1.

Source Characteristics
Nine sources were quantitative studies published in peerreviewed journals, 2 were conference abstracts, and 1 was a
letter to the editor. Almost half the sources identiﬁed in this
scoping review were from the United States transplant centers
(N = 5), 4 sources were from European groups (Belgium,
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Figure 1. PRISMA ﬂow diagram showing the ﬁnal sources included in the scoping review.

Germany, Spain, and Switzerland), and the remaining 3 were
from Australia and Japan. Quantitative studies and conference
abstracts used predominantly observational cross-sectional
and prospective methodologies; one was a secondary analysis.
The letter to the editor involved a post-hoc analysis of the data
collected in an earlier study.

Terminology
Deﬁnitions of sleep quality as a clinical or theoretical concept
were not consistent. Poor sleep quality was referred to as
poor sleep,28,29,33 sleep difﬁculty,24 insomnia,32,38 and sleep
disturbance.34

Findings and Topic Areas
Sample Characteristics
Studies’ participant sample sizes of lung transplant recipients
ranged from 12 to 219 patients. While participant samples
were comprised exclusively of recipients of lung transplant in
10 sources, 2 studies used a sub-sample of lung transplant recipients among other solid organ transplant recipients.24,28
Convenience sampling strategy was the predominant sampling
method of the selected sources.

The authors analyzed 12 included sources and grouped the ﬁndings according to the 4 major topics: objective sleep quality
measures, subjective sleep quality measures, combination of
subjective and objective sleep quality measures, and the
studies of risk factors and associations of sleep quality.
Subjective, objective or a combination of both sleep quality
measurement tools were used across all sources and the majority of sources (N = 9) were reported under more than 1 topic
area. Table 4 provides a visual representation of the distribution
of reported instruments across included sources.
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Table 4. Subjective and Objective Measures of Sleep Quality in Lung
Transplant Recipients Across Included Sources.
Author and Year

Objective SQ
Measures

Subjective SQ Measures

PSG Actigraphy PSQI ISI ESS
Burkhalter et al,
201728
Fatigati et al,
201629
Gilmour et al,
201530
Hernandez et al,
201531
Reilly-Spong et al,
201324
Rohde et al,
201732
Sawhney et al,
202033
Sommerwerck
et al, 201635
Smith &
Blumenthal,
201634
Testelmans et al,
202136
Tokuno et al,
202037
Yo et al, 201938

Single
Question
X

X
X
X

X
X

X

X
X
X

X

X

X
X

X

X
X
X

ESS = Epworth Sleepiness Scale; ISI = Insomnia Severity Index; LTR = lung
transplant recipients; PSG = polysomnography; PSQI = Pittsburgh Sleep Quality
Instrument; SQ = sleep quality.

Objective sleep quality measures. Of the objective measures,
actigraphy was used in 1 study.24 In lung transplant recipients
who wore actigraphy devices, benchmarks for poor sleep
inclusive of sleep latency greater than 30 minutes was
present in 33%; total sleep time of less than 6 hours was
present in 33%; and lack of sleep efﬁciency < 85% was present
in 50%.24 Three sources31,35,36 used PSG to explore sleep characteristics. They found that although there was a high prevalence of sleep disordered breathing in their respective
samples, of signiﬁcance to sleep quality measures, mean total
sleep time in patients with and without sleep disordered breathing were all equally poor (eg, under 6 hours). Lack of sleep efﬁciency, as reported under 85% via PSG, was consistent across
all 3 publications;31,35,36 however, slightly better in recipients
without sleep disordered breathing.35
Subjective sleep quality measures. Subjective measures of sleep
quality were used in most sources (N = 9). The PSQI was
used in 4 studies,24,29,33,37 ISI in 3 studies,30,32,38 and ESS
was used in 6 studies.30–33,35,36 Additional subjective measures
of sleep quality included questions from the Wisconsin Sleep
Cohort study to assess the frequency of sleep complaints as
they related to insomnia,32 single item question from the

Kidney Disease Quality of Life Short Form instrument,28 and
a single item of sleep disturbance on the Beck Depression
Inventory-II.34
Perceived subjective sleep quality as measured by PSQI demonstrated that between 32%-81% of recipients experience poor
sleep.24,29,33,37 While 3 researchers used a PSQI cutoff greater
than 5,24,33,37 Fatigati et al29 found that one-third of their sample
were categorized as poor sleepers as evidenced by a higher PSQI
cutoff score (PSQI > 8). In the PSQI subscales, reported subjective
ﬁndings included increase in the use of sleeping aids,37 sleep disturbances,29 prolonged sleep latency,29,33 decreased sleep duration,29,33
and decreased sleep efﬁciency.24,33 Both Sawney et al33 and
Reilly-Spong et al24 found that most common factors for sleep initiation insomnia were getting up to use the bathroom, coughing or
snoring loudly, feeling too hot or cold, and having pain.
The prevalence of insomnia as measured by ISI was found to
be 32%-52%.30,32,38 While Gilmour et al30 did not specify the
cutoff ISI score, Rohde et al32 used the cutoff score equal or
greater to 10, while Yo et al38 used the ISI cutoff score of
greater than 15. Both Rohde et al32 and Yo et al38 found that
there was a higher prevalence of insomnia in female recipients.
Additionally, Gilmour et al30 differentiated the presence of
insomnia in patients diagnosed with a form of chronic rejection
bronchiolitis obliterans syndrome with ﬁndings that symptoms
of insomnia were found in 52% of patients with bronchiolitis
obliterans syndrome and 44% of patients without it.
The prevalence of daytime sleepiness as measured by ESS
varied across sources.30–33,35,36 Sawney et al33 reported the prevalence of excessive daytime sleepiness (ESS > 9) in 29% of the
sample. Both Rohde et al32 and Sawney et al33 noted that a
higher score on ESS was documented for individuals with poor
sleep quality or insomnia. For example, Rohde et al32 found that
higher ISI score was correlated with greater ESS score (mean
score 9.7 in insomnia group vs 6.9 with no insomnia). Similarly,
Sawney et al33 described an ESS mean score of 8.3 in those recipients with PSQI > 5 compared to ESS mean score of 5.6 in those
with PSQI < 5. This was divergent from ﬁndings of Hernandez
et al31 and Testelmans et al,36 who postulated that ESS scoring
was remarkably low in participants with and without SDB and
deemed this measure of low predictability for sleep problems.
The 3 additional measures of subjective sleep quality in
revealed that the most frequently reported sleep complaints as
assessed via Wisconsin Sleep Questionnaire were waking up
repeatedly during the night at 42%, followed by not feeling
rested during the day, no matter how many hours of sleep
you had at 35% and difﬁculty getting to sleep (32%).32 One
item from the Kidney Disease Quality of Life-Short Form
instrument revealed that, in the sub-sample of 123, poor sleep
quality (cutoff value less than 6) was prevalent in approximately one-third of participants at various time trajectories
after transplant. Sleep quality was best 12 months after transplant (23%) and worst at 6 months (36%).28 Conﬂicting with
these reports were ﬁndings from the post hoc analysis on the
single item of sleep of the Beck Depression Inventory-II revealing that only 8% of recipients reported that their sleep was disturbed and 5% reported more severe sleep problems.34
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Combined (subjective and objective) sleep quality measures. Four
studies used objective and objective measures within their
studies.24,31,35,36 When comparing self-report and actigraphy
metrics, sleep durations were similar (6.78 and 6.65 hours,
respectively)
and
sleep
latencies
also
correlated
(29.82 minutes and 28.2 minutes). However, the correlations
between overall PSQI scores and actigraphy data for total
sleep time and sleep latency were not sufﬁcient.24 Similarly,
the 3 studies31,35,36 using sleep indices via PSG and subjective
reports of day-time sleepiness by ESS did not report signiﬁcant
correlations as ESS scores were surprisingly low even in recipients with SDB.
Risk factors and associations with sleep quality. Risk factors for
poor sleep quality were assessed only in a few studies. On univariate analyzes, associations with poor sleep quality were noted in
those patients who were younger29,32,33 and were females.29,38
Only female gender was a signiﬁcant predictor of poor sleep
quality on a multivariate level.29 Several investigators found an
inverse relationship between poor sleep quality or insomnia
scores and the mental health domains of health related quality of
life such as anxiety and depression.28,29,33,34,38 This was consistent
with Reilly-Spong et al24 who found moderately strong correlations between self-reports of sleep on the PSQI and symptoms
of depression, anxiety, fatigue, and pain across all organ transplant
recipients in their sample. Furthermore, patients with persistently
poor sleep quality over time experienced lower mean global
quality of life in a study by Burkhalter et al28

Discussion
The authors conducted a scoping review to collect and summarize available evidence on sleep quality after lung transplantation and its associated subjective and objective measures.
Although ﬁndings demonstrated that some research was available, information on sleep quality after lung transplantation
was limited as only 12 sources met the eligibility criteria for
the review. Yet, the results are multi-dimensional, highlighting
the complexity of sleep quality as a clinical concept. Results
suggest that while the majority of selected sources agreed that
recipients experience poor sleep, this area of research is understudied.24,28–30,32,33,37
Only 4 of the selected sources explored objective measures of
sleep quality. They all consistently demonstrated decreased total
sleep time and lack of sleep efﬁciency in at least one-third of their
respective samples.24,31,35,36 Currently accepted measures of
sleep quantity, such as total sleep time, sleep latency, sleep efﬁciency, and wake after sleep onset, may not completely characterize people’s total sleep experiences.12 Literature notes that they
may reﬂect non-sleep phenomena such as overall health status
or pain. Alternatively, there is a possibility that sleep quality
may translate into different aspects of sleep for different individuals.12 Several investigators highlighted increased rates of sleep
disordered breathing after lung transplantation, which may also
result in inadequate sleep duration or sleep fragmentation33
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affecting one’s sleep quality. It is largely unknown whether variations in these objective indices were due to a high prevalence of
sleep disordered breathing (eg, obstructive sleep apnea) and
whether correction of the underlying pathology of sleep disordered breathing may lead to an improvement in these markers
and overall sleep quality. While PSG is expensive and intrusive
and actigraphy can be considered an alternative, researchers need
to consider variabilities in techniques as measures obtained in the
sleep lab may differ from those obtained by actigraphy.9
Currently, there is no literature correlating these measures in
the population of lung transplant recipients.
Most of the available data on sleep quality in recipients
were obtained from self-report questionnaires. Their advantages involve low cost and non-invasive nature. At this time
it was unclear whether they correlated well with objective
measures. It is recognized that self-report data may be prone
to the response bias affecting estimation of the targeted construct.39 For example, those recipients who are affected by
poor sleep quality may be more eager to participate in
studies of sleep quality. Sleep experts also noted that since
certain stages of sleep involve loss of consciousness, patients
may not be reliable self-observers of particular behaviors that
were being documented in self-reports.19 Despite these disadvantages, patients’ experiences about sleep contribute to a rich
and meaningful information to aid with the study of sleep
quality domains.
Lung transplant recipients may be especially predisposed to
the effects of poor sleep. The complex interactions of the recipient, graft, immunosuppression, and underlying comorbidities
may create complex challenges in relation to sleep and sleep
quality. Recipients undergo physiological changes from
impaired immunity due to immunosuppressive therapy and
may experience further health challenges as a result of posttransplant complications. Complications such as episodes of
acute or chronic organ rejection may result in dyspnea, although
Gilmour et al30 found similar rates of insomnia in individuals
with and without bronchiolitis obliterans syndrome. Several
studies found that female recipients were at a higher risk for
poor sleep. One possible explanation may relate to the presence
of menopausal symptoms since the average age included in the
study samples was over 50 years old. Only 1 study investigated
an association between immunosuppression and insomnia
symptoms in lung transplant recipients with ﬁndings that
there was a relationship between calcineurin drugs such as
tacrolimus and poor sleep.32 Rohde et al32 explained that pharmacodynamics of tacrolimus may inﬂuence sleep and wake
cycles with infusion of interleukin-2 into the central nervous
system. Other agents known for their adverse sleep side
effects include corticosteroids, which are the cornerstone of
immunosuppressive regimens after transplantation. The association between corticosteroids and sleep quality after lung transplantation has not been investigated.
Psychosocial health states, such as anxiety and depression,
were also found to be correlated with poor sleep. This relationship, however, may be bi-directional as anxiety and depression
have an established relationship with altered sleep.40
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Gaps
This scoping review highlighted that signiﬁcant gaps exist not
only in our understanding of sleep quality in lung transplant
recipients but also in standardized deﬁnitions of the concept
and its associated operational measures. Subjective measures,
such as PSQI, ISI, and ESS, used in most publications
possess strong psychometric properties, but none of them are
validated in the population of lung transplant recipients.
Objective indices across PSG and actigraphy have not been
assessed for inter-measure reliability. Additionally, although
sleep parameters can be measured by self-reports (eg sleep
duration in PSQI), it can be argued that studies are strengthened
by having both subjective and objective measurements especially of physiological variables.41 This scoping review
included 4 studies using a combination of actigraphy or PSG
and self-reports but with variable results.

Implications for Research and Clinical Practice
This scoping review helped to identify several areas for future
research in the arena of sleep quality after lung transplantation.
Lack of standard conceptual and operational deﬁnitions of sleep
quality limits its research and, therefore, greater conceptual
clarity is warranted. This could be achieved by a concept analysis or formal concept mapping. Given the availability of sleep
measures, psychometric testing of the existing subjective sleep
quality in lung transplant recipients would further enhance
validity of the studies. Systematic studies of correlations
between objective and subjective constructs can provide
further insight on standardization of measures. Furthermore,
as wearable sleep monitoring devices become more widely
used, further research can focus on evaluation of sleep
metrics and their relationship to sleep quality via this novel
technology. Ultimately, given the positive effects of sleep on
health, the end goal is the formation of best practices around
assessments of sleep quality to mitigate negative consequences
that poor sleep may have on different domains of lung recipients’ health and well-being.

Limitations
To the authors’ knowledge, this is the ﬁrst scoping review
investigating the concept of sleep quality after lung transplantation. Several limitations were identiﬁed. Sources in a language
other than English and those available before the year 2011
were excluded, limiting review of the literature to the last 10
years to reﬂect current practices and evolution of transplantation over the years. There was always a possibility of selection
bias if the authors did not identify all available published and
unpublished sources pertinent to the topic. The available
research included in the review was predominantly observational, single-center, ﬁrst-phase, and lacked replication.
Cross-sectional designs precluded measurements of incidence
and were not able to make causal inferences. Absence of
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methodological appraisal and risk of bias evaluation were limitations of the scoping review methodology.42

Conclusion
Poor sleep quality, a prevalent problem after lung transplantation, remains an under-studied clinical problem. Extant research
is limited in standardized deﬁnitions and operationalized sleep
quality measures. Subjective and objective assessments are
available to measure sleep quality but need to be validated in
lung transplant recipients. This review highlights the need for
multi-dimensional examination of sleep quality after lung transplantation. Further rigorous research is needed to standardize
measures of sleep quality and to further examine potential
risk factors that affect sleep after lung transplantation.
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